Cost-Utility Analysis of Telaprevir in Combination with Peginterferon Alpha and Ribavirin in Previously Untreated Patients with Chronic Hepatitis in a Romanian Setting
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1125
https://www.valueinhealthjournal.com/article/S1098-3015(13)03030-1/fulltext
Title :
Cost-Utility Analysis of Telaprevir in Combination with Peginterferon Alpha and Ribavirin in Previously Untreated Patients with Chronic Hepatitis in a Romanian Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03030-1&doi=10.1016/j.jval.2013.08.1125
First page :
A499
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
978